Emergent Biosolutions, Inc.

• locale

  United States

• market

  STOCKS

• industry

  Drug Manufacturers - Specialty & Generic

• website

  www.emergentbiosolutions.com

• ipo date

  Nov 15, 2006

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

*Estimate based on analyst consensus